免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Accipiolx

K号: K182177 · 2018-10-26

决定日期2018-10-26
产品代码QAS
咨询委员会RA
决定实质等同

器械摘要

Accipiolx is the device name listed in this FDA 510(k) record. The listed applicant is Maxq-Al , Ltd.. It received FDA 510(k) clearance on 2018-10-26 under 510(k) number K182177. The device is classified under product code QAS. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Accipiolx?

Accipiolx is a medical device that received FDA 510(k) clearance on 2018-10-26. The listed applicant is Maxq-Al , Ltd.. The 510(k) number is K182177.

When did Accipiolx receive FDA 510(k) clearance?

Accipiolx received FDA 510(k) clearance on 2018-10-26, under 510(k) number K182177.

Who is the listed applicant for Accipiolx?

The FDA 510(k) record lists Maxq-Al , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Accipiolx?

The FDA product code for Accipiolx is QAS.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Maxq-Al , Ltd.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:QAS)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑